Abstract:Abstract The development of high‐throughput technologies has enhanced our understanding of small non‐coding RNAs (sncRNAs) and their crucial roles in various diseases, including atrial fibrillation (AF). This study aimed to systematically delineate sncRNA profiles in AF patients. PANDORA‐sequencing was used to examine the sncRNA profiles of atrial appendage tissues from AF and non‐AF patients. Differentially expressed sncRNAs were identified using the R package DEGseq 2 with a fold change >2 and p < 0.05. The target genes of the differentially expressed sncRNAs were predicted using MiRanda and RNAhybrid. Gene Ontology (GO) categories and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed. In AF patients, the most abundant sncRNAs were ribosomal RNA‐derived small RNAs (rsRNAs), followed by transfer RNA‐derived small RNAs (tsRNAs), and microRNAs (miRNAs). Compared with non‐AF patients, 656 rsRNAs, 45 miRNAs, 191 tsRNAs and 51 small nucleolar RNAs (snoRNAs) were differentially expressed in AF patients, whereas no significantly differentially expressed piwi‐interacting RNAs were identified. Two out of three tsRNAs were confirmed to be upregulated in AF patients by quantitative reverse transcriptase polymerase chain reaction, and higher plasma levels of tsRNA 5006c‐LysCTT were associated with a 2.55‐fold increased risk of all‐cause death in AF patients (hazard ratio: 2.55; 95% confidence interval, 1.56–4.17; p < 0.001). Combined with our previous transcriptome sequencing results, 32 miRNA, 31 snoRNA, 110 nucleus‐encoded tsRNA, and 33 mitochondria‐encoded tsRNA target genes were dysregulated in AF patients. GO and KEGG analyses revealed enrichment of differentially expressed sncRNA target genes in AF‐related pathways, including the ‘calcium signaling pathway’ and ‘adrenergic signaling in cardiomyocytes.’ The dysregulated sncRNA profiles in AF patients suggest their potential regulatory roles in AF pathogenesis. Further research is needed to investigate the specific mechanisms of sncRNAs in the development of AF and to explore potential biomarkers for AF treatment and prognosis.

Identification of long non-coding RNAs as novel biomarker and potential therapeutic target for atrial fibrillation in old adults.

Identification of Atrial Fibrillation-Related lncRNA Based on Bioinformatic Analysis

Functional Analysis of Serum Long Noncoding RNAs in Patients with Atrial Fibrillation

Identification of Genes and Key Pathways Underlying the Pathophysiological Association Between Nonalcoholic Fatty Liver Disease and Atrial Fibrillation

Research Progress of LncRNAs in Atrial Fibrillation

Identification of Functional Lncrnas in Atrial Fibrillation by Integrative Analysis of the Lncrna‐mrna Network Based on Competing Endogenous RNAs Hypothesis

Genome-wide screening of functional long noncoding RNAs in the epicardial adipose tissues of atrial fibrillation

Comprehensive RNA-Seq Data Analysis Identifies Key mRNAs and lncRNAs in Atrial Fibrillation.

Identification of senescence-related genes for potential therapeutic biomarkers of atrial fibrillation by bioinformatics, human histological validation, and molecular docking

Bioinformatics Analysis on Lncrna and Mrna Expression Profiles for Novel Biological Features of Valvular Heart Disease with Atrial Fibrillation

RNA Sequencing Profiling Reveals Key Mrnas and Long Noncoding RNAs in Atrial Fibrillation

The roles of long noncoding RNAs in atrial fibrillation

Small non‐coding RNA signatures in atrial appendages of patients with atrial fibrillation

Differential expression of long non-coding RNA in atrial tissue of atrial fibrillation rats

Integrated analysis of the lncRNA-miRNA-mRNA network based on competing endogenous RNA in atrial fibrillation

Identification of atrial fibrillation-associated lncRNAs in atria from patients with rheumatic mitral valve disease.

Circulating exosome long non-coding RNAs are associated with atrial structural remodeling by increasing systemic inflammation in atrial fibrillation patients

Evaluation of Lncrna Expression Pattern and Potential Role in Heart Failure Pathology

Transcriptome Analysis of Canine Cardiac Fat Pads: Involvement of Two Novel Long Non-Coding RNAs in Atrial Fibrillation Neural Remodeling.

Circulating Long Noncoding RNA GAS5 As a Novel Biomarker for Patients with Atrial Fibrillation

Identification of Atrial Fibrillation-Related Circular RNAs and Constructing the Integrative Regulatory Network of Circular RNAs, Micrornas and Mrnas by Bioinformatics Analysis.